Group One Trading
TRVI icon

Group One Trading’s Trevi Therapeutics TRVI Stock Holding History

Group One Trading’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Sell
22,600
-58,300
-72% -$653K ﹤0.01% 3883
2025
Q4 		$1.01M Sell
80,900
-105,700
-57% -$1.22M ﹤0.01% 2880
2025
Q3 		$1.71M Sell
186,600
-14,500
-7% -$109K ﹤0.01% 2470
2025
Q2 		$1.1M Buy
201,100
+142,100
+241% +$884K ﹤0.01% 2676
2025
Q1 		$371K Buy
59,000
+52,400
+794% +$250K ﹤0.01% 3395
2024
Q4 		$27.2K Buy
+6,600
New +$21.1K ﹤0.01% 5501

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Group One Trading's TRVI Position: Q1 2026 in Review

Group One Trading opened a new position in Trevi Therapeutics (TRVI) in Q1 2026: 25,930 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #3766 among its holdings. This is a return to the name: Group One Trading previously reported a position in TRVI as recently as Q1 2025.

Group One Trading first reported a position in TRVI in Q4 2024 and has held it in 3 quarters since. The position peaked at $369K in Q1 2025. 198 funds tracked by Wall St. Rank hold TRVI as of Q1 2026.

  • Group One Trading held 25,930 shares of Trevi Therapeutics worth $309K as of Q1 2026.
  • Trevi Therapeutics was a new Group One Trading position in Q1 2026.
  • Trevi Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3766 holding.
  • Group One Trading first reported a position in Trevi Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Group One Trading's Trevi Therapeutics position peaked at $369K in Q1 2025.
  • 198 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.